<DOC>
	<DOCNO>NCT00337766</DOCNO>
	<brief_summary>Patients undergo cardiac surgery could develop excessive perioperative bleed require transfusion blood product . Desmopressin ( DDAVP ) , already use patient von Willebrand syndrome , could reduce bleed transfusion requirement patient administer ev ( 0.3 mg/kg ) 20-30 minute postoperatively .</brief_summary>
	<brief_title>Desmopressin Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>undergo cardiac surgery excessive bleeding age &lt; 18 sign write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Blood Loss</keyword>
	<keyword>Postoperative Blood loss</keyword>
</DOC>